JTL
TVTX icon

Jupiter Topco LLC’s Travere Therapeutics TVTX Stock Holding History

Jupiter Topco LLC’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$643M Buy
+11,324,191
New +$502M 0.26% 83

Other funds holding TVTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Jupiter Topco LLC's TVTX Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 11,324,191 shares worth $643M. The stake represents 0.26% of the portfolio and ranks #83 among its holdings.

291 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Jupiter Topco LLC held 11,324,191 shares of Travere Therapeutics worth $643M as of Q2 2026.
  • Travere Therapeutics was a new Jupiter Topco LLC position in Q2 2026.
  • Travere Therapeutics made up 0.26% of Jupiter Topco LLC's portfolio in Q2 2026, its #83 holding.
  • 291 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.